Istesso
develops and commercializes novel drugs for the treatment of autoimmune diseases... Read moreIstesso
develops and commercializes novel drugs for the treatment of autoimmune diseases... Read more
News
Jan 30, 2023
City A.M.
Istesso: Hambro SPAC ditches merger talks with biotech firm
Jan 30, 2023
MarketScreener
Istesso: Hambro Perks will not merge with IP Group drug firm Istesso
Aug 31, 2022
FirstWord Pharma
Istesso: Istesso announces initiation of Phase 2b trial of MBS2320
Jul 15, 2019
4-traders
Istesso: IP : Istesso Ltd - MBS2320 Phase 2a results
Jul 15, 2019
FE Investegate
Istesso: IP Group PLC : Istesso announces positive P2a study of MBS2320
Dec 12, 2018
4-traders
Istesso: IP : Istesso Limited - Istesso completes £6 million fundraise
Istesso Competitors
1
2
3
4
5
6
7
8
9
10